Introduction to TMOZOLMIDE (100mg / 250 mg)

TMOZOLMIDE 

Temozolomide (100mg / 250 mg)

Introduction to TMOZOLMIDE (100mg / 250 mg)

TMOZOLMIDE is an oral chemotherapy medication used primarily to treat certain types of brain tumors, such as glioblastoma multiforme and anaplastic astrocytoma. It is available in different dosages, including 100mg and 250mg, to accommodate various treatment plans and patient needs.

Mechanism of Action

• Alkylating Agent: TMOZOLMIDE belongs to the alkylating agents class, which works by damaging the DNA of cancer cells, inhibiting their ability to reproduce and leading to cell death.
• Cell Cycle Non-Specific: It acts at all phases of the cell cycle, making it effective against rapidly dividing tumor cells.

Indications and Usage

• Primary Treatment: Used for newly diagnosed high-grade glioblastoma multiforme in conjunction with radiotherapy.
• Recurrent Brain Tumors: Also indicated for refractory anaplastic astrocytoma when previous treatments have failed.

Dosage and Administration

• Dosage Forms: Available in 100mg and 250mg capsules.
• Treatment Regimens: The dosage and treatment schedule depend on the type of tumor, patient’s body surface area, and overall treatment plan, typically following a 5-day oral intake cycle repeated every 28 days.

Side Effects and Management

• Common Adverse Effects: Nausea, vomiting, fatigue, and hematological changes like thrombocytopenia and neutropenia.
• Management Strategies: Supportive care includes antiemetics for nausea, monitoring blood counts, and dose adjustments as necessary.

Clinical Efficacy

• Survival Benefits: Studies have shown that TMOZOLMIDE can improve survival rates in glioblastoma patients, especially when combined with other treatments like radiotherapy.
• Response Rates: It has been effective in reducing tumor size and slowing progression in some patients.

Special Considerations

• Contraindications: Not suitable for patients with a history of hypersensitivity to TMOZOLMIDE or any of its components.
• Drug Interactions: Potential interactions with other medications, including those metabolized by the liver enzyme CYP3A4, should be carefully monitored.

Conclusion

TMOZOLMIDE, available in 100mg and 250mg capsules, is a vital tool in the treatment of certain brain tumors. Its efficacy, combined with manageable side effects, makes it a key component of therapeutic strategies for glioblastoma multiforme and anaplastic astrocytoma. Personalized treatment plans and careful monitoring are essential to maximize the benefits of TMOZOLMIDE therapy.  A group of highly skilled pharmaceutical professionals founded a specialist pharmaceutical in February 2018 such as Steris Healthcare Pvt Ltd.Sterispharma is a WHO, GMP, and ISO-certified pharma company based in Navi Mumbai. They provide quality medicines at the best price to customers in India as per the standard parameters of WHO. With a steris online pharmacy, you can buy and get home delivery of medicines at your doorsteps. Our main goal at Steris is to provide a wide range of healthcare goods to meet the various needs of the healthcare sector. Steris is dedicated to satisfying the needs of the healthcare industry, whether it be with regard to specialty treatments, rare disease meds, or necessary pharmaceuticals. Steris healthcare products range covers almost every cadre of requirement in today's Medical scenario, widely prescribed under categories like Cardiology, Asthama, Respiratory, Nasal, Diabetic, Endocrinology, Cadiology, Gastrology, Orthopaedic, Anti-infective/antibiotic, General, Urology, Neurology, Nephrology, Oncology, Gynaecology, Pediatric, Dental & Derma range of Products.

For further more information:

 EMAIL:  info@sterispharma.com  / contact@sterispharma.com    

CALL:: 7877551268, 8209542042, 8955945010, 6377716668   

WHATSAPP:: MONA, HARSHITA, SAKSHI, SHWETA   

BUY NOW